Silence Therapeutics
SLN
#7337
Rank
โ‚ฌ0.47 B
Marketcap
10,06ย โ‚ฌ
Share price
-3.21%
Change (1 day)
92.30%
Change (1 year)

Revenue for Silence Therapeutics (SLN)

Revenue in 2026 (TTM): โ‚ฌ0.71 Million

According to Silence Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.73 Million. In 2025 the company made a revenue of โ‚ฌ0.47 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ40.63 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Silence Therapeutics from 2021 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ0.71 M51.11%
2025 โ‚ฌ0.47 M-98.83%
2024 โ‚ฌ40.63 M9.13%
2023 โ‚ฌ37.23 M43.34%
2022 โ‚ฌ25.97 M27.12%
2021 โ‚ฌ20.43 M